1. Home
  2. OSPN vs ETON Comparison

OSPN vs ETON Comparison

Compare OSPN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$11.36

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$17.27

Market Cap

411.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
ETON
Founded
1991
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
411.9M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
OSPN
ETON
Price
$11.36
$17.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$17.00
$29.67
AVG Volume (30 Days)
693.4K
275.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.31%
N/A
EPS Growth
297.30
N/A
EPS
0.76
N/A
Revenue
$243,179,000.00
$39,011,000.00
Revenue This Year
$0.69
$107.23
Revenue Next Year
$1.96
$29.72
P/E Ratio
$14.66
N/A
Revenue Growth
3.43
23.29
52 Week Low
$10.17
$11.09
52 Week High
$18.13
$23.00

Technical Indicators

Market Signals
Indicator
OSPN
ETON
Relative Strength Index (RSI) 48.42 57.51
Support Level $11.00 $15.93
Resistance Level $12.21 $17.59
Average True Range (ATR) 0.45 0.98
MACD 0.05 0.18
Stochastic Oscillator 69.23 50.55

Price Performance

Historical Comparison
OSPN
ETON

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: